Effect of chronic administration of centrally acting compounds on chloramphenicol metabolism in schizophrenic patients.
D000328:Adult; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D002701:Chloramphenicol / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D002908:Chronic Disease; D005260:Female; D005965:Glucuronates / Q000652:urine; D006207:Half-Life; D006801:Humans; D007275:Injections, Intravenous; D008103:Liver Cirrhosis / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009574:Nitro Compounds / Q000652:urine; D010634:Phenobarbital / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D010640:Phenothiazines; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*
D014150:Antipsychotic Agents; D005965:Glucuronates; D009574:Nitro Compounds; D010640:Phenothiazines; D002701:Chloramphenicol; D010634:Phenobarbital